Journal of
Veterinary Medicine and Animal Health

  • Abbreviation: J. Vet. Med. Anim. Health
  • Language: English
  • ISSN: 2141-2529
  • DOI: 10.5897/JVMAH
  • Start Year: 2009
  • Published Articles: 386

Full Length Research Paper

Comparison of Montanideâ„¢ GEL 01 and oily MontanideTM ISA 50 in presenting a peptide to the immune system of dogs

Pedro Enrique Encinosa Guzmán
  • Pedro Enrique Encinosa Guzmán
  • Department of Animal Biotechnology, Center for Genetic Engineering and Biotechnology, (CIGB), Havana, Cuba.
  • Google Scholar
Anayram Perera Martin
  • Anayram Perera Martin
  • Altahabana Veterinary Clinic of the Canine Unit in the Ministry of Interior (MININT), Cuba.
  • Google Scholar
Yamil Bello Soto
  • Yamil Bello Soto
  • Department of Animal Biotechnology, Center for Genetic Engineering and Biotechnology, (CIGB), Havana, Cuba.
  • Google Scholar
Frank Luis Ledesma Bravo
  • Frank Luis Ledesma Bravo
  • Department of Animal Biotechnology, Center for Genetic Engineering and Biotechnology, (CIGB), Havana, Cuba.
  • Google Scholar
William Fernández Herrera
  • William Fernández Herrera
  • Altahabana Veterinary Clinic of the Canine Unit in the Ministry of Interior (MININT), Cuba.
  • Google Scholar
Carlos Pérez Heredia
  • Carlos Pérez Heredia
  • Center for Genetic Engineering and Biotechnology of Camagüey (CIGB- Camagüey), Cuba.
  • Google Scholar
Llilian Gómez Pérez
  • Llilian Gómez Pérez
  • Department of Animal Biotechnology, Center for Genetic Engineering and Biotechnology, (CIGB), Havana, Cuba.
  • Google Scholar
Nemecio González
  • Nemecio González
  • Center for Genetic Engineering and Biotechnology of Camagüey (CIGB- Camagüey), Cuba.
  • Google Scholar
Mario Pablo Estrada
  • Mario Pablo Estrada
  • Department of Animal Biotechnology, Center for Genetic Engineering and Biotechnology, (CIGB), Havana, Cuba.
  • Google Scholar
Alina Rodríguez-Mallon
  • Alina Rodríguez-Mallon
  • Department of Animal Biotechnology, Center for Genetic Engineering and Biotechnology, (CIGB), Havana, Cuba.
  • Google Scholar


  •  Received: 14 August 2020
  •  Accepted: 26 October 2020
  •  Published: 28 February 2021

References

Aucouturier J, Dupuis L, Ganne V (2001). Adjuvants designed for veterinary and human vaccines. Vaccine 19:2666-2672.
Crossref

 

Canales M, Enriquez A, Ramos E, Cabrera D, Dandie H, Soto A, Falcon V, Rodriguez M, de la Fuente J (1997) Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick. Vaccine 15(4):414-422. 
Crossref

 
 

Carter JM (1994). Techniques for Conjugation of Synthetic Peptides to Carrier Molecules. In: Dunn BM, Pennington MW (eds) Peptide Analysis Protocols. Humana Press, Totowa, NJ, pp. 155-191.
Crossref

 
 

Garcia-Garcia JC, Soto A, Nigro F, Mazza M, Joglar M, Hechevarria M, Lamberti J, de la Fuente J (1998). Adjuvant and immunostimulating properties of the recombinant Bm86 protein expressed in Pichia pastoris. Vaccine 16(9-10):1053-1055. 
Crossref

 
 

Gil FI, Brun A, Wigdorovitz ARC, Martínez-Torrecuadrada JL, Casal I, Salinas J, Borca MV, Escribano JM (2001). High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Letters 488(1-2):13-17. 
Crossref

 
 

Guerrero FD, Miller RJ, Pérez de León AA (2012). Cattle tick vaccines: Many candidate antigens, but will a commercially viable product emerge? International Journal for Parasitology 42(5):421-427. 
Crossref

 
 

Guide for the Care and Use of Laboratory Animals (2011). Eighth Edition. The National Academies Press,

View

 
 

Heegaard PMH, Dedieu L, Johnson N, Le Potier M-F, Mockey M, Mutinelli F, Vahlenkamp T, Vascellari M, Sørensen NS (2011). Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Archives of Virology 156(2):183-202. 
Crossref

 
 

Hendrick MJ, Goldschmidt MH, Shofer FS, Wang Y-Y, Somlyo AP (1992). Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Research 52:5391-5394.

 
 

Hilleman MR (2000). Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine 18:1436-1447.
Crossref

 
 

Jackson D, Fitzmaurice C, Brown L, Zeng W (2000). Preparation and properties of totally synthetic immunogens. Vaccine 18:355-361.
Crossref

 
 

Jahouh F, Hou S-j, Kováč P, Banoub JH (2012). Determination of glycation sites by tandem mass spectrometry in a synthetic lactose-bovine serum albumin conjugate, a vaccine model prepared by dialkyl squarate chemistry. Rapid Communications in Mass Spectrometry 26(7):749-758.
Crossref

 
 

Kahn CM, Line S, Merck, Co (2010). The Merck veterinary manual. Whitehouse Station, N.J. : Merck & Co.,

 
 

Kurella S, Manocha M, Sabhnani L, Thomas B, Rao DN (2000). New age adjuvants and delivery systems for subunit vaccines. Indian Journal of Clinical Biochemistry 15(Suppl):83-100.
Crossref

 
 

Langeveld JP, Casal JI, Osterhaus AD, Cortes E, de Swart R, Vela C, Dalsgaard K, Puijk WC, Schaaper WM, Meloen RH (1994). First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs. Journal of Virology 68(7):4506-4513.
Crossref

 
 

Langeveld JPM, Casal I, Cortés J, Van de Wetering E, Boshuizen G, Schaaper RS, Dalsgaard WMM, Meloen KHR (1994). Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12(15):1473-1480.
Crossref

 
 

Leroux-Roels G (2010). Unmet needs in modern vaccinology: adjuvants to improve the immune response Vaccine 28(Suppl 3):C25-36. 
Crossref

 
 

Rodríguez-Mallon A, Bechara GH, Zacarias RM, Benavides-Ortiz E, Soto-Rivas JL, Gómez-Ramírez AP, Jaimes-Olaya JA, Estrada-García MP (2013). Inhibition of Ehrlichia canis and Babesia canis transmission among ticks fed together on dogs vaccinated with Bm86 antigen. Open Journal of Animal Sciences 3(3A):24-32.
Crossref

 
 

Rodríguez-Mallon A, Fernández E, Encinosa PE, Bello Y, Méndez-Pérez L, Cepero L, Pérez D, González M, Garay H, Reyes O, Méndez L, Estrada MP (2012). A novel tick antigen shows high vaccine efficacy against the dog tick, Rhipicephalus sanguineus. Vaccine 30:1782-1789
Crossref

 
 

Rodríguez-Mallon A, Gonzalez LJ, Encinosa Guzman PE, Bechara GH, Sanches GS, Pousa S, Cabrera G, Cabrales A, Garay H, Mejias R, Lopez Alvarez JR, Bello Soto Y, Almeida F, Guirola O, Rodriguez Fernandez R, Fuentes Castillo A, Mendez L, Jimenez S, Licea-Navarro A, Portela M, Duran R, Estrada MP (2020). Functional and mass spectrometric evaluation of an anti-tick antigen based on the P0 peptide conjugated to Bm86 protein. Pathogens 9(6). 
Crossref

 
 

Simerska P, Ziora Z, Fagan V, Goodwin D, Edrous F, Toth I (2013). Design, synthesis and characterisation of mannosylated ovalbumin lipid core peptide self-adjuvanting vaccine delivery system. Drug Delivery and Translational Research pp. 1-10. 
Crossref

 
 

Vascellari M, Melchiotti E, Bozza MA, Mutinelli F (2003). Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. Journal of Veterinary Medicine Series A 50:286-291. 
Crossref

 
 

Verdier F, Burnett R, Michelet-Habchi C, Moretto P, Fievet-Groyne F, Sauzeat E (2005). Aluminium assay and aluminium containing vaccines in the Cynomolgus monkey. Vaccine 23(11):1359-1367. 
Crossref

 
 

Willadsen P (2008). Anti-tick vaccines.Ticks: Biology, Disease and Control. Cambridge University Press Cambridge pp. 424-446.
Crossref